Pemphigus vulgaris: the other half of the story
AUTOR(ES)
Kalish, Richard S.
FONTE
American Society for Clinical Investigation
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=387261Documentos Relacionados
- The other half of the Story
- Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent
- Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.
- Pemphigus vulgaris
- Pemphigus vulgaris